Accelevir develops viral load assays and variant discovery sequencing workflows for infectious disease, vaccine, and viral vector safety programs. We provide strain-specific detection and variant-level resolution to guide therapeutic decision-making and regulatory submissions.
Capabilities:
- qPCR/dPCR for absolute viral load quantification.
- Amplicon- and metagenomic-based NGS for variant discovery and surveillance.
- Multiplex workflows for detecting multiple viral variants simultaneously.
- Rapid turnaround for outbreak response or clinical trial decision support.
Applications:
- Vaccine efficacy monitoring via viral load reduction.
- Resistance variant detection for antivirals.
- Breakthrough infection analysis in clinical trials.
- Pathogen surveillance in preclinical models.